Europe Neuromodulation Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2027 - COVID-19 Impact and Regional Analysis by Technology (External (Non-Invasive) Neuromodulation, and Internal Neuromodulation); Application (Chronic Pain Management, Failed Back Syndrome, Epilepsy, Tremor, Incontinence, Depression, Dystonia, Gastroparesis, Parkinson’s Disease, Obsessive-Compulsive Disorder, and Migraine); End User (Hospitals, Clinics, and Home Healthcare)

No. of Pages: 117    |    Report Code: TIPRE00016296    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Neuromodulation Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Europe Neuromodulation Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Europe Neuromodulation Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Growing Developments in Neuromodulation Technology
5.2 Market Opportunities
  • 5.2.1 Rising Demand for Neurostimulation Devices to Treat Chronic Pain
5.3 Future Trends
  • 5.3.1 Technological Advancements
5.4 Impact of Drivers and Restraints

6. Europe Neuromodulation Market Regional Analysis

6.1 Europe Neuromodulation Market Overview
6.2 Europe Neuromodulation Market Revenue 2017-2027 (US$ Million)
6.3 Europe Neuromodulation Market Forecast Analysis

7. Europe Neuromodulation Market Analysis – by Technology

7.1 External Neuromodulation
  • 7.1.1 Overview
  • 7.1.2 External Neuromodulation: Europe Neuromodulation Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Internal Neuromodulation
  • 7.2.1 Overview
  • 7.2.2 Internal Neuromodulation: Europe Neuromodulation Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Neuromodulation Market Analysis – by Application

8.1 Chronic Pain Management
  • 8.1.1 Overview
  • 8.1.2 Chronic Pain Management: Europe Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Failed Back Syndrome
  • 8.2.1 Overview
  • 8.2.2 Failed Back Syndrome: Europe Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
8.3 Epilepsy
  • 8.3.1 Overview
  • 8.3.2 Epilepsy: Europe Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Tremor
  • 8.4.1 Overview
  • 8.4.2 Tremor: Europe Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Incontinence
  • 8.5.1 Overview
  • 8.5.2 Incontinence: Europe Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
8.6 Depression
  • 8.6.1 Overview
  • 8.6.2 Depression: Europe Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
8.7 Dystonia
  • 8.7.1 Overview
  • 8.7.2 Dystonia: Europe Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
8.8 Gastroparesis
  • 8.8.1 Overview
  • 8.8.2 Gastroparesis: Europe Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
8.9 Parkinson's Disease
  • 8.9.1 Overview
  • 8.9.2 Parkinson's Disease: Europe Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
8.10 Obsessive-Compulsive Disorder
  • 8.10.1 Overview
  • 8.10.2 Obsessive-Compulsive Disorder: Europe Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
8.11 Migraine
  • 8.11.1 Overview
  • 8.11.2 Migraine: Europe Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

9. Europe Neuromodulation Market Analysis – by End User

9.1 Hospitals
  • 9.1.1 Overview
  • 9.1.2 Migraine: Europe Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
9.2 Clinics
  • 9.2.1 Overview
  • 9.2.2 Migraine: Europe Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
9.3 Home Healthcare
  • 9.3.1 Overview
  • 9.3.2 Migraine: Europe Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

10. Europe Neuromodulation Market – Europe Analysis

10.1 Europe
  • 10.1.1 Europe Neuromodulation Market Breakdown, by Key Country, 2020 and 2027 (%)
  • 10.1.1.1 Europe Neuromodulation Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 UK: Europe Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.1.1 UK: Europe Neuromodulation Market Breakdown, by Technology
    • 10.1.1.1.2 UK: Europe Neuromodulation Market Breakdown, by Application
    • 10.1.1.1.3 UK: Europe Neuromodulation Market Breakdown, by End User
  • 10.1.1.2 Germany: Europe Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.2.1 Germany: Europe Neuromodulation Market Breakdown, by Technology
    • 10.1.1.2.2 Germany: Europe Neuromodulation Market Breakdown, by Application
    • 10.1.1.2.3 Germany: Europe Neuromodulation Market Breakdown, by End User
  • 10.1.1.3 France: Europe Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.3.1 France: Europe Neuromodulation Market Breakdown, by Technology
    • 10.1.1.3.2 France: Europe Neuromodulation Market Breakdown, by Application
    • 10.1.1.3.3 France: Europe Neuromodulation Market Breakdown, by End User
  • 10.1.1.4 Russia: Europe Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.4.1 Russia: Europe Neuromodulation Market Breakdown, by Technology
    • 10.1.1.4.2 Russia: Europe Neuromodulation Market Breakdown, by Application
    • 10.1.1.4.3 Russia: Europe Neuromodulation Market Breakdown, by End User
  • 10.1.1.5 Italy: Europe Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.5.1 Italy: Europe Neuromodulation Market Breakdown, by Technology
    • 10.1.1.5.2 Italy: Europe Neuromodulation Market Breakdown, by Application
    • 10.1.1.5.3 Italy: Europe Neuromodulation Market Breakdown, by End User
  • 10.1.1.6 Rest of Europe: Europe Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.6.1 Rest of Europe: Europe Neuromodulation Market Breakdown, by Technology
    • 10.1.1.6.2 Rest of Europe: Europe Neuromodulation Market Breakdown, by Application
    • 10.1.1.6.3 Rest of Europe: Europe Neuromodulation Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Europe Neuromodulation Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Abbott
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Boston Scientific Corporation
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Medtronic
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 NeuroPace, Inc.
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 NeuroSigma, Inc.
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 NEVRO CORP.
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Synapse Biomedical Inc.
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Soterix Medical Inc
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Integer Holdings Corporation
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Magstim
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - E Market

The List of Companies - Europe Neuromodulation Market

  1. Abbott
  2. Boston Scientific Corporation
  3. Medtronic
  4. NeuroPace, Inc.
  5. NeuroSigma, Inc.
  6. NEVRO CORP.
  7. Synapse Biomedical Inc.
  8. Soterix Medical Inc
  9. Integer Holdings Corporation
  10. Magstim
europe-neuromodulation-market